Abrogation of graft-versus-host disease following allotransplantation of cytotoxically deficient bone marrow across major histocompatibility barriers.
Selvaggi
G
G
Diabetes Research Institute Cell Transplant Center, University of Miami School of Medicine, Florida 33136, USA.
Inverardi
L
L
Levy
R B
RB
Brendel
M D
MD
Spielman
J
J
Mintz
D H
DH
Podack
E R
ER
Ricordi
C
C
D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D054353:Perforin